G. Möller

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

J. Ringe, G. Möller, 2009, Rheumatology International.

Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis

M. Amling, P. Fardellone, H. Kruse, 2009, Drugs & aging.

Importance of Calcium Co-Medication in Bisphosphonate Therapy of Osteoporosis

J. Ringe, G. Möller, S. A. P. Geest, 2006, Drugs & aging.

Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial.

S. Cummings, M. Bhandari, S. Boonen, 2012, The Journal of bone and joint surgery. American volume.

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications

N. Freemantle, R. Horne, C. Cooper, 2010, Archives of osteoporosis.

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

P. Geusens, H. Resch, A. Fahrleitner-Pammer, 2015, Osteoporosis International.

Shape model-based semi-automatic morphometric assessment of vertebral deformities in clinical practice

D. Banzer, R. Andresen, G. Möller, 2011, Osteologie.

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU® study

N. Freemantle, C. Cooper, A. Díez-Pérez, 2011, Osteoporosis International.